176 related articles for article (PubMed ID: 19485418)
1. The QTK loop is essential for the communication between the N-terminal atpase domain and the central cleavage--ligation region in human topoisomerase IIalpha.
Bendsen S; Oestergaard VH; Skouboe C; Brinch M; Knudsen BR; Andersen AH
Biochemistry; 2009 Jul; 48(27):6508-15. PubMed ID: 19485418
[TBL] [Abstract][Full Text] [Related]
2. Salvicine functions as novel topoisomerase II poison by binding to ATP pocket.
Hu CX; Zuo ZL; Xiong B; Ma JG; Geng MY; Lin LP; Jiang HL; Ding J
Mol Pharmacol; 2006 Nov; 70(5):1593-601. PubMed ID: 16914642
[TBL] [Abstract][Full Text] [Related]
3. The ATP-operated clamp of human DNA topoisomerase IIalpha: hyperstimulation of ATPase by "piggy-back" binding.
Campbell S; Maxwell A
J Mol Biol; 2002 Jul; 320(2):171-88. PubMed ID: 12079377
[TBL] [Abstract][Full Text] [Related]
4. A three-dimensional quantitative structure-activity relationship study of the inhibition of the ATPase activity and the strand passing catalytic activity of topoisomerase IIalpha by substituted purine analogs.
Jensen LH; Liang H; Shoemaker R; Grauslund M; Sehested M; Hasinoff BB
Mol Pharmacol; 2006 Nov; 70(5):1503-13. PubMed ID: 16880287
[TBL] [Abstract][Full Text] [Related]
5. The N-terminal domain of human topoisomerase IIalpha is a DNA-dependent ATPase.
Gardiner LP; Roper DI; Hammonds TR; Maxwell A
Biochemistry; 1998 Dec; 37(48):16997-7004. PubMed ID: 9836594
[TBL] [Abstract][Full Text] [Related]
6. Separation of bisdioxopiperazine- and vanadate resistance in topoisomerase II.
Sorensen TK; Grauslund M; Jensen PB; Sehested M; Jensen LH
Biochem Biophys Res Commun; 2005 Sep; 334(3):853-60. PubMed ID: 16053917
[TBL] [Abstract][Full Text] [Related]
7. Communication between the ATPase and cleavage/religation domains of human topoisomerase IIalpha.
Bjergbaek L; Kingma P; Nielsen IS; Wang Y; Westergaard O; Osheroff N; Andersen AH
J Biol Chem; 2000 Apr; 275(17):13041-8. PubMed ID: 10777608
[TBL] [Abstract][Full Text] [Related]
8. Hairpin structures formed by alpha satellite DNA of human centromeres are cleaved by human topoisomerase IIalpha.
Jonstrup AT; Thomsen T; Wang Y; Knudsen BR; Koch J; Andersen AH
Nucleic Acids Res; 2008 Nov; 36(19):6165-74. PubMed ID: 18824478
[TBL] [Abstract][Full Text] [Related]
9. Investigating the role of the latch in the positive supercoiling mechanism of reverse gyrase.
Rodríguez AC
Biochemistry; 2003 May; 42(20):5993-6004. PubMed ID: 12755601
[TBL] [Abstract][Full Text] [Related]
10. Hindering the strand passage reaction of human topoisomerase IIalpha without disturbing DNA cleavage, ATP hydrolysis, or the operation of the N-terminal clamp.
Oestergaard VH; Giangiacomo L; Bjergbaek L; Knudsen BR; Andersen AH
J Biol Chem; 2004 Jul; 279(27):28093-9. PubMed ID: 15123700
[TBL] [Abstract][Full Text] [Related]
11. Quinolone action against human topoisomerase IIalpha: stimulation of enzyme-mediated double-stranded DNA cleavage.
Bromberg KD; Burgin AB; Osheroff N
Biochemistry; 2003 Apr; 42(12):3393-8. PubMed ID: 12653542
[TBL] [Abstract][Full Text] [Related]
12. Substituted purine analogues define a novel structural class of catalytic topoisomerase II inhibitors.
Jensen LH; Thougaard AV; Grauslund M; Søkilde B; Carstensen EV; Dvinge HK; Scudiero DA; Jensen PB; Shoemaker RH; Sehested M
Cancer Res; 2005 Aug; 65(16):7470-7. PubMed ID: 16103101
[TBL] [Abstract][Full Text] [Related]
13. Self-association and DNA binding properties of the human topoisomerase IIA alpha2HTH module.
Morant-Lhomel A; René B; Zargarian L; Troalen F; Mauffret O; Fermandjian S
Biochimie; 2006; 88(3-4):253-63. PubMed ID: 16213649
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of ferrocene derivatives on the catalytic activity of topoisomerase IIalpha and beta--distinct mode of action of two derivatives.
Sai Krishna AD; Panda G; Kondapi AK
Arch Biochem Biophys; 2005 Jun; 438(2):206-16. PubMed ID: 15907782
[TBL] [Abstract][Full Text] [Related]
15. C-terminal regions of topoisomerase IIalpha and IIbeta determine isoform-specific functioning of the enzymes in vivo.
Linka RM; Porter AC; Volkov A; Mielke C; Boege F; Christensen MO
Nucleic Acids Res; 2007; 35(11):3810-22. PubMed ID: 17526531
[TBL] [Abstract][Full Text] [Related]
16. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
Liang H; Wu X; Yalowich JC; Hasinoff BB
Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
[TBL] [Abstract][Full Text] [Related]
17. The transducer domain is important for clamp operation in human DNA topoisomerase IIalpha.
Oestergaard VH; Bjergbaek L; Skouboe C; Giangiacomo L; Knudsen BR; Andersen AH
J Biol Chem; 2004 Jan; 279(3):1684-91. PubMed ID: 14583603
[TBL] [Abstract][Full Text] [Related]
18. A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity.
Huang H; Chen Q; Ku X; Meng L; Lin L; Wang X; Zhu C; Wang Y; Chen Z; Li M; Jiang H; Chen K; Ding J; Liu H
J Med Chem; 2010 Apr; 53(8):3048-64. PubMed ID: 20353152
[TBL] [Abstract][Full Text] [Related]
19. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
Dickey JS; Osheroff N
Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
[TBL] [Abstract][Full Text] [Related]
20. Probing the interaction of the cytotoxic bisdioxopiperazine ICRF-193 with the closed enzyme clamp of human topoisomerase IIalpha.
Patel S; Jazrawi E; Creighton AM; Austin CA; Fisher LM
Mol Pharmacol; 2000 Sep; 58(3):560-8. PubMed ID: 10953049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
